Bates SE - Search Results

1

A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer.

Kelly RJ, Draper D, Chen CC, Robey RW, Figg WD, Piekarz RL, Chen X, Gardner ER, Balis FM, Venkatesan AM, Steinberg SM, Fojo T, Bates SE. Kelly RJ, et al. Among authors: bates se. Clin Cancer Res. 2011 Feb 1;17(3):569-80. doi: 10.1158/1078-0432.CCR-10-1725. Epub 2010 Nov 16. Clin Cancer Res. 2011. PMID: 21081657 Free PMC article. Clinical Trial.

2

Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines.

Herzog CE, Trepel JB, Mickley LA, Bates SE, Fojo AT. Herzog CE, et al. Among authors: bates se. J Natl Cancer Inst. 1992 May 6;84(9):711-6. doi: 10.1093/jnci/84.9.711. J Natl Cancer Inst. 1992. PMID: 1349044

3

Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.

Lai GM, Moscow JA, Alvarez MG, Fojo AT, Bates SE. Lai GM, et al. Among authors: bates se. Int J Cancer. 1991 Nov 11;49(5):688-95. doi: 10.1002/ijc.2910490511. Int J Cancer. 1991. PMID: 1682279

4

P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines.

Lai GM, Chen YN, Mickley LA, Fojo AT, Bates SE. Lai GM, et al. Among authors: bates se. Int J Cancer. 1991 Nov 11;49(5):696-703. doi: 10.1002/ijc.2910490512. Int J Cancer. 1991. PMID: 1682280

5

Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas.

Wilson WH, Chabner BA, Bryant G, Bates S, Fojo A, Regis J, Jaffe ES, Steinberg SM, Goldspiel BR, Cheson BD, et al. Wilson WH, et al. J Clin Oncol. 1995 Feb;13(2):381-6. doi: 10.1200/JCO.1995.13.2.381. J Clin Oncol. 1995. PMID: 7531220 Clinical Trial.

6

Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy.

Wilson WH, Jamis-Dow C, Bryant G, Balis FM, Klecker RW, Bates SE, Chabner BA, Steinberg SM, Kohler DR, Wittes RE. Wilson WH, et al. Among authors: bates se. J Clin Oncol. 1995 Aug;13(8):1985-94. doi: 10.1200/JCO.1995.13.8.1985. J Clin Oncol. 1995. PMID: 7636539 Clinical Trial.

7

Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy.

Wilson WH, Bates SE, Fojo A, Bryant G, Zhan Z, Regis J, Wittes RE, Jaffe ES, Steinberg SM, Herdt J, et al. Wilson WH, et al. Among authors: bates se. J Clin Oncol. 1995 Aug;13(8):1995-2004. doi: 10.1200/JCO.1995.13.8.1995. J Clin Oncol. 1995. PMID: 7636540 Clinical Trial.

8

EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.

Wilson WH, Bryant G, Bates S, Fojo A, Wittes RE, Steinberg SM, Kohler DR, Jaffe ES, Herdt J, Cheson BD, et al. Wilson WH, et al. J Clin Oncol. 1993 Aug;11(8):1573-82. doi: 10.1200/JCO.1993.11.8.1573. J Clin Oncol. 1993. PMID: 7687667 Clinical Trial.

9

Molecular diagnosis of multidrug resistance.

Herzog CE, Bates SE. Herzog CE, et al. Among authors: bates se. Cancer Treat Res. 1994;73:129-47. doi: 10.1007/978-1-4615-2632-2_7. Cancer Treat Res. 1994. PMID: 7710903 Review. No abstract available.

10

Chemoresistance in the clinic: overview 1994.

Bates SE, Regis JI, Robey RW, Zhan Z, Scala S, Meadows BJ. Bates SE, et al. Bull Cancer. 1994 Dec;81 Suppl 2:55s-61s. Bull Cancer. 1994. PMID: 7727860 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

407 results

Search Page